Health Care • Industrial Specialties
$8.88 ▼ -0.10
(-1.11%)
MKT CAP: $88.2M • VOL: 77.6K
52W L $7 52W H $17
LAKE // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $192.6M | $167.2M | $124.7M |
| YoY Revenue Growth % | +15.2% | +34.1% | — |
| Gross Profit | $63.3M | $68.7M | — |
| Gross Margin % | 32.9% | 41.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$15.5M | -$9.3M | $6.0M |
| Operating Margin % | -8.1% | -5.5% | 4.8% |
| Net Income (GAAP) | -$25.3M | -$18.1M | $5.4M |
| EBITDA (Normalized) | -$15.0M | -$8.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$15.8M | -$15.9M | $10.9M |
| Capital Expenditures (CapEx) | $671.0K | $1.5M | — |
| Free Cash Flow (FCF) | -$16.4M | -$17.4M | $10.9M |
| FCF Margin % | -8.5% | -10.4% | 8.8% |
| Return on Invested Capital (ROIC %) | -9.5% | -5.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $129.1M | $146.6M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR LAKE.